HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margit Blömacher Selected Research

Leukocyte L1 Antigen Complex (Calgranulin)

6/2016Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margit Blömacher Research Topics

Disease

3Ulcerative Colitis
01/2023 - 06/2016
1Inflammation (Inflammations)
11/2019
1Adenoma (Adenomas)
09/2015
1Adenocarcinoma
09/2015
1Neoplasms (Cancer)
09/2015
1Carcinoma (Carcinomatosis)
09/2015

Drug/Important Bio-Agent (IBA)

1vedolizumabIBA
11/2019
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
06/2016
1golimumabFDA Link
06/2016
1AntibodiesIBA
06/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2016
1coroninIBA
09/2015
1coronin proteinsIBA
09/2015

Therapy/Procedure

2Therapeutics
11/2019 - 06/2016
1Biological Therapy
01/2023